Cargando…
Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
Ovarian cancer cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly associated with tumor progression in ovarian cancer. Here, we report that active recombi...
Autores principales: | Yu, Yu, Rahmanto, Yohan Suryo, Lee, Meng-Horng, Wu, Pei-Hsun, Phillip, Jude M., Huang, Chuan-Hsiang, Vitolo, Michele I., Gaillard, Stephanie, Martin, Stuart S., Wirtz, Denis, Shih, Ie-Ming, Wang, Tian-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043408/ https://www.ncbi.nlm.nih.gov/pubmed/29643476 http://dx.doi.org/10.1038/s41388-018-0241-0 |
Ejemplares similares
-
Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer
por: Yu, Yu, et al.
Publicado: (2019) -
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
por: Suryo Rahmanto, Yohan, et al.
Publicado: (2020) -
Therapeutic Inducers of Apoptosis in Ovarian Cancer
por: Binju, Mudra, et al.
Publicado: (2019) -
Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
por: Padilla, Monica Angelica Amaya, et al.
Publicado: (2019) -
Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear
por: Perrella, Gina, et al.
Publicado: (2022)